Related Experiment Video
Updated: Nov 22, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
NK cell-based cancer immunotherapy: from basic biology to clinical development.
Sizhe Liu1, Vasiliy Galat2,3,4, Yekaterina Galat4,5
1Department of Urology, Feinberg School of Medicine, Northwestern University, 303 E. Superior St., Lurie Research Building 6-117, Chicago, IL, 60611, USA.
Natural killer (NK) cells are key immune cells for fighting abnormal cells. This review covers NK cell biology, cancer immunotherapy development, and future directions for this promising cancer treatment.
Area of Science:
- Immunology
- Cancer Biology
- Cell Therapy
Background:
- Natural killer (NK) cells are crucial immune effector cells that combat abnormal cells.
- Unlike T cells, NK cell activation relies on direct receptor interactions, bypassing antigen processing.
- Their unique activation mechanism makes NK cells highly attractive for cancer immunotherapy.
Purpose of the Study:
- To review current knowledge of NK cell biology.
- To summarize pre-clinical and clinical advancements in NK cell-based cancer therapies.
- To discuss the progress, challenges, and future outlook of NK cell immunotherapy.
Main Methods:
- Literature review of NK cell biology.
- Analysis of ongoing pre-clinical studies.
- Evaluation of current clinical trials in NK cell therapy.
- Discussion of research trends and challenges.
Main Results:
- NK cells offer a distinct pathway for immune activation against cancer.
- Significant progress has been made in developing engineered NK cell therapies.
- Various pre-clinical and clinical studies are exploring NK cell potential.
Conclusions:
- NK cell biology provides a foundation for novel cancer immunotherapies.
- Engineering NK cells shows great promise for effective cancer treatment.
- Continued research is essential to overcome challenges and advance NK cell therapy.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

